Document is current

Any future updates will be listed below

Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer

Crossref DOI link: https://doi.org/10.1007/s10549-014-3148-7

Published Online: 2014-10-01

Published Print: 2014-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark